ArticleRespirology case reports2026
Pulmonary Amyloidosis Diagnosed by Transbronchial Lung Biopsy: A Three-Case Series With Diverse Radiological Manifestations.
Article in Respirology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pulmonary amyloidosis is a rare disease with diverse radiological manifestations that may mimic malignancy or diffuse interstitial lung disease. Although conventional forceps transbronchial lung biopsy (TBLB) is an established less invasive diagnostic method, its clinical role may differ according to disease presentation. We report three patients with pulmonary amyloidosis diagnosed by conventional forceps TBLB. Two presented with nodular lesions mimicking malignancy; TBLB established the diagnosis, and systemic evaluation showed no extrapulmonary involvement, supporting localized pulmonary amyloidosis. The third presented with progressive weight loss and diffuse interlobular septal thickening. TBLB unexpectedly demonstrated pulmonary amyloid deposition, prompting systemic and haematological evaluation that revealed systemic AL amyloidosis associated with multiple myeloma. These cases illustrate distinct roles of conventional forceps TBLB: distinguishing localized nodular amyloidosis from malignancy and, in diffuse alveolar-septal disease, providing an initial clue prompting evaluation for systemic amyloidosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.